Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011
by National Cancer Institute (NCI).
Recruitment status was Recruiting
Study NCT00433433 Information provided by National Cancer Institute (NCI)
First Received on February 8, 2007. Last Updated on July 20, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Additional conditions recognized in this trial
Hodgkin Disease
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
bleomycin sulfate
filgrastim
ABVE regimen
cyclophosphamide
dacarbazine
doxorubicin hydrochloride
etoposide
prednisone
procarbazine hydrochloride
vinblastine sulfate
vincristine sulfate
fludeoxyglucose F 18
radiation therapy
Additional drug interventions recognized in this trial
Bleomycin
Doxorubicin
Lenograstim
Procarbazine
Vinblastine
Vincristine
More general drug interventions related to this trial
Adjuvants, Immunologic
Alkylating Agents
Anti-Inflammatory Agents
Antibiotics, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
European Organisation for Research and Treatment of Cancer - EORTC
Lymphoma Study Association
Intergruppo Italiano Linfomi
Back to top of Main Content